- Global Kinetics Corporation Ltd Established
Global Kinetics
About Us
Global Kinetics was established in 2007 to commercialise innovative technology developed by Professor Malcolm Horne, from the Florey Institute of Neuroscience & Mental Health (the largest Neuroscience research team in Australia and the Southern Hemisphere), and Dr Rob Griffiths, for the precise recording, quantification and reporting of movement symptoms of neurological disease.
The lead product, the Personal’s KinetiGraph® system (PKG®) movement recording is a unique and useful tool for neurologists in the management of Parkinson’s disease.
Company Overview
Global Kinetics
Global Kinetics Pty Ltd (GK), a novel digital health company, is revolutionising the management of Parkinson’s disease by providing the first continuous and objective measurement of patients’ symptoms in everyday environments.
The PKG System
History of the PKG system
Initial development of the technology behind the PKG® system began in the late 1990s by Professor Malcolm Horne and Dr Rob Griffiths at the world-renowned Florey Institute of Neuroscience and Mental Health in Melbourne, Australia. The pair worked on developing the data logger, assessment and report creation technology and in 2007, Global Kinetics Corporation (GKC) was established to commercialise this innovative technology.
The PKG® system has evolved to include advanced monitoring technology and reporting capabilities and in 2016 the next generation data logger featuring an interactive touch-screen design – the PKG Watch was launched.
Key milestones for the PKG® system:
- 2007
2007
2007
January 1, 2007 - 2009
2009
2009
January 1, 2009- 1st external funding
- 2010
2010
2010
January 1, 2010- EU Declaration of Conformity submitted
- 2011
2011
2011
January 1, 2011- Series 2 capital raise
- Initial product development
- POC clinical studies underway
- 2012
2012
2012
January 8, 2012- TGA Registration
- CE Mark
- 1st product in Australia
- 1st product in Europe
- 1st publication
- 2014
2014
2014
January 1, 2014- Series 3 Capital raise
- 53 Clinical sites
- 1st patent granted
- US Market launch
- 2015
2015
2015
January 1, 2015- Series 4 Capital raise
- US FDA Clearance
- CE Mark 11a
- 1st Reimbursement Sweden
- 2016
2016
2016
January 1, 2016- Series 5 Capital raise
- Second Generation device receives FDA clearance
- 2017
2017
2017
January 1, 2017- +3 million PKG recording hrs
- Second Generation device receives CE mark
- 1st US patent granted
- Fast Company Top 10 in Health
- 2018
2018
2018
January 1, 2018- Series 6 Capital raise
- Roll down: creation of Global Kinetics Pty Ltd and assignment of all asset and liabilities for shares
- 2019
2019
2019
January 1, 2019- Continuous Monitoring product launched
- Clinical Trial Services business launched
- 2020
2020
2020
January 1, 2020- +50 million PKG recording hrs
- 23 peer-reviewed studies
- RPM Pilot